Fundamental dimension Equity attribute | JNJLeader $263.81▼-1.42% Cap $635.8BP/E 40.0x QuantScore62/100 | ABBVPeer $282.78▼-0.92% Cap $499.7BP/E 79.7x QuantScore55/100 | AMGNPeer $424.94▼-1.75% Cap $229.7BP/E 26.2x QuantScore58/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
86/100 |
96/100 |
Valuation Multiples, PEG & DCF upside | 57/100 | 39/100 | 85/100 |
Health Piotroski, Altman Z, leverage & liquidity | 72/100 | 49/100 | 32/100 |
Growth Revenue / earnings growth & margins | 53/100 | 37/100 | 59/100 |
Sentiment Analyst ratings, targets & revisions | 41/100 | 66/100 | 16/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 40.0x | 79.7x | 26.2x |
Forward P/E (next FY) | 23.7x | 20.3x | 18.4x |
EV / EBITDA (TTM) | 21.5x | 26.6x | 15.5x |
Price / Sales | 6.4x | 7.8x | 6.0x |
Price / Free Cash Flow | 30.9x | 27.4x | 22.6x |
PEG ratio | -1.09 | 1.17 | 0.83 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 9 / 9 | 8 / 9 |
Altman Z-Score | 5.46 (Safe) | 2.70 (Grey) | 2.31 (Grey) |
Total debt / equity | 0.55 | -11.93 | 4.90 |
Quick ratio | 0.7x | 0.7x | 1.1x |
Interest coverage | 32.0x | 6.5x | 4.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +6.0% | +8.6% | +9.9% |
Net income growth YoY | +90.6% | -1.2% | +88.5% |
Gross margin (TTM) | 68.8% | 71.5% | 72.7% |
Operating margin (FY) | 27.2% | 32.8% | 29.1% |
FCF margin (FY) | 20.9% | 29.1% | 22.0% |
5. Trailing price performancePrice change over period |
1M return | -2.0% | +7.8% | +10.2% |
3M return | +1.8% | +11.2% | +16.0% |
6M return | +14.4% | +42.1% | +19.6% |
Year to date | +27.5% | +25.0% | +29.8% |
1Y return | +37.1% | +25.1% | +40.1% |
3Y return | +74.3% | +97.4% | +51.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $284.62 +7.9% upside | $123.86 -56.2% premium | $860.35 +102.5% upside |
Wall Street consensus target | $285.31 +8.1% · range $260.00–$320.00 | $292.21 +3.3% · range $235.00–$320.00 | $401.16 -5.6% · range $230.00–$500.00 |
Consensus stance | 53% Buy40% Hold8% Sell | 73% Buy25% Hold2% Sell | 54% Buy39% Hold7% Sell |